We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cytokines Involved in Trauma Death

By HospiMedica staff writers
Posted on 12 Mar 2007
A new study indicates that cytokine levels reflect severity of injury and that death in severe trauma may be the result of an exhausted cytokine response.

Researchers at Copenhagen University Hospital (Denmark) performed a study of 265 consecutive adult trauma patients admitted directly from the trauma scene. More...
Patients were admitted between 2003 and 2004, and the length of the subsequent observation period was 18 months. The researchers serially measured levels of interleukin-6 (IL-6), a pro-inflammatory cytokine, and IL-10, an anti-inflammatory cytokine. The first sample was taken within 40 minutes of the accident; successive samples were taken at six, 12, and 24 hours after the trauma.

The researchers found that there was an almost immediate release of IL-6 and IL-10, and that the injury severity score was significantly correlated with IL-6 and IL-10 levels at all time points. At 30 days after the trauma, the mortality rate was 10.9%. The results of the study were reported at the 36th Critical Care Congress of the Society of Critical Care Medicine, held during February 2007 in Orlando (FL, USA).

"Nonsurvivors had the highest scores. IL-6 scores were four times higher than baseline and IL-10 levels were 10 times higher than baseline at the time of death,” said lead author Jakob Stensballe, M.D., Ph.D., of the department of anesthesia. "Death could be the result of an exhausted IL-10 response. The body doesn't have the ability to prioritize its response to inflammation after a certain point. This is a part of a cytokine storm that happens in trauma.”

The researchers suggested that a clinical implication of the study might be to stimulate the IL-10 response by giving corticosteroids to improve survival, and suggested that a randomized trial of corticosteroids and IL-10 response might offer insight into the treatment of acute trauma patients.


Related Links:
Copenhagen University Hospital

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.